Sirona Biochem To Present At Industry’s Premier Conference - BIO International Convention 2015

Vancouver, British Columbia – May 4, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB), announces that its Chief Business Development Officer, Attila Hajdu, will be presenting at BIO International, taking place June 15-18 at the Pennsylvania Convention Center, Philadelphia PA.

BIO International is the industry’s premier conference and partnering opportunity. It is the largest global event for the biotechnology industry and attracts the biggest names in biotech and pharma. With more than 15,000 expected to attend, BIO International offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

“Bio is like the Superbowl of conferences,” said Attila Hajdu, Chief Business Development Officer at Sirona Biochem. “It’s another important step in continuing our discussions with the types of companies that have the ability to commercialize our innovative compounds.”

About BIO International Convention

BIO International is the world’s largest, most influential biotech meeting. The convention regularly attracts the most powerful biotech and pharma players from 65 countries, offering powerful business partnering, networking and education that go far beyond professional development.

• Face-to-face partnering meetings with thousands of companies
• Company presentations from the industry’s up-and-coming innovators
• World-renowned speakers leading Keynote Luncheons and Super Sessions
• Session tracks covering timely issues in R&D, IP, Business Development, Commercialization, Digital Health, Personalized Medicine and more
• 1,700+ exhibitors offering a competitive edge in all fields
•Exciting networking and social events
For more information about the convention, please visit

For more information regarding this press release, please contact:

Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064

About Sirona Biochem

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France. The company specializes in the stabilization of carbohydrate molecules, with the goal of improving compounds’ efficacy and safety. Sirona Biochem’s compounds are patented as new chemical entities for maximum commercial protection and revenue potential. Newly developed compounds are licensed to leading companies around the world in return for licensing and milestone fees and ongoing royalty payments. TFChem, Sirona Biochem’s wholly-owned French laboratory is a recipient of multiple French national scientific awards and a European Union and French government grant. For more information visit

Help employers find you! Check out all the jobs and post your resume.

Back to news